â˘
VV
VVOS
Vivos Therapeutics, Inc. Common Stock
polygonSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
20.90M
Volume
41.25K
52W High
$7.95
52W Low
$1.78
Open
$1.83
Prev Close
$1.83
Day Range
1.83 - 1.90
About Vivos Therapeutics, Inc. Common Stock
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Latest News
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight
GlobeNewswire Inc.â˘22h ago
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
GlobeNewswire Inc.â˘Yesterday
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
GlobeNewswire Inc.â˘Dec 15
Vivos Reports 7% Sales Drop
The Motley Foolâ˘Aug 20
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
GlobeNewswire Inc.â˘Jun 27
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
GlobeNewswire Inc.â˘Jun 12
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire Inc.â˘May 14
Vivos Therapeuticsâ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
GlobeNewswire Inc.â˘Apr 9